8. Market Segmentation
- By Type: Preclinical and clinical testing, molecule screening, target identification, de novo drug design, drug optimization.
- By Application: Neurology, infectious diseases, oncology, and others.
- By Drug Type: Small molecules and large molecules.
- By Offering: Software and services.
- By Technology: Machine learning (including deep learning, supervised learning, reinforcement learning, and others).
- By End-User: Pharmaceutical and biotechnology companies, contract research organizations, academic institutions, and others.
9. Regional Outlook
- North America: Dominates the global AI drug discovery market due to early adoption, a strong focus on R&D, and a well-established pharmaceutical sector.
- Asia Pacific: Expected to grow rapidly due to the increasing demand for effective drug discovery solutions and a surge in AI startups in the region.
10. Competitive Landscape
Leading companies in the AI drug discovery market include IBM, Microsoft, Atomwise Inc., Cloud Pharmaceuticals, Benevolent AI, and BIO AGE. These companies are leveraging partnerships and innovative AI platforms to accelerate drug discovery and development.
11. Key Developments in the Industry
- AI-Based Platforms: New AI platforms like the pay-as-you-go AI platform for drug development launched by AI companies.
- Strategic Partnerships: Collaborations such as the multi-target drug development agreement between Genentech and Genesis Therapeutics are driving innovation in the industry.
12. Future Outlook
The AI in drug discovery market is set for significant growth due to technological advancements, increased collaborations, and rising demand for efficient drug discovery solutions. However, challenges such as high costs, regulatory hurdles, and skill shortages will need to be addressed to fully realize AI’s potential in the pharmaceutical industry
Read Also: https://www.healthcarewebwire.com/bionic-eye-market/
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/artificial-intelligence-in-drug-discovery
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5010
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare